Single-Blind, Placebo Phase-in Trial of Two Escalating Doses of Selegiline in the Chronic Fatigue Syndrome

Publisher： Karger

E-ISSN： 1423-0224|37|3|150-154

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.37, Iss.3, 1998-04, pp. : 150-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diurnal Variation of Adrenocortical Activity in Chronic Fatigue Syndrome

By  

Neuropsychobiology, Vol. 38, Iss. 4, 1998-11 ,pp. : 213-217

Karger

Access to resources Recommend Favorite

Salivary Cortisol Profiles in Chronic Fatigue Syndrome

By  

Neuropsychobiology, Vol. 37, Iss. 1, 1997-12 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Hormonal Responses to Exercise in Chronic Fatigue Syndrome

By  

Neuropsychobiology, Vol. 43, Iss. 1, 2001-01 ,pp. : 34-41

Karger

Access to resources Recommend Favorite

Hypothalamic-Pituitary-Adrenal Axis Function in Chronic Fatigue Syndrome

By  

Neuropsychobiology, Vol. 55, Iss. 2, 2007-06 ,pp. : 112-120

Karger

Access to resources Recommend Favorite

Sleep Quality Perception in the Chronic Fatigue Syndrome: Correlations with Sleep Efficiency, Affective Symptoms and Intensity of Fatigue

By  

Neuropsychobiology, Vol. 56, Iss. 1, 2007-11 ,pp. : 40-46

Karger

Access to resources Recommend Favorite